110 related articles for article (PubMed ID: 23980682)
21. Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models.
Singh D; Gupta M; Sarwat M; Siddique HR
Crit Rev Oncol Hematol; 2022 Aug; 176():103751. PubMed ID: 35752426
[TBL] [Abstract][Full Text] [Related]
22. Optimising the therapeutic ratio in head and neck cancer.
Eckert AW; Schubert J; Taubert H
Lancet Oncol; 2010 Jun; 11(6):511-2. PubMed ID: 20522377
[No Abstract] [Full Text] [Related]
23. Insulin regulates GLUT1-mediated glucose transport in MG-63 human osteosarcoma cells.
Cifuentes M; García MA; Arrabal PM; Martínez F; Yañez MJ; Jara N; Weil B; Domínguez D; Medina RA; Nualart F
J Cell Physiol; 2011 Jun; 226(6):1425-32. PubMed ID: 21321933
[TBL] [Abstract][Full Text] [Related]
24. Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue.
Reinicke K; Sotomayor P; Cisterna P; Delgado C; Nualart F; Godoy A
J Cell Biochem; 2012 Feb; 113(2):553-62. PubMed ID: 21938742
[TBL] [Abstract][Full Text] [Related]
25. Apigenin and Breast Cancers: From Chemistry to Medicine.
Nabavi SM; Habtemariam S; Daglia M; Nabavi SF
Anticancer Agents Med Chem; 2015; 15(6):728-35. PubMed ID: 25738871
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
[TBL] [Abstract][Full Text] [Related]
27. Cancer stem cells in head and neck squamous cell cancer.
Prince ME; Ailles LE
J Clin Oncol; 2008 Jun; 26(17):2871-5. PubMed ID: 18539966
[TBL] [Abstract][Full Text] [Related]
28. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
29. The utility of GLUT-1 immunolocalization in cell blocks: An adjunct to the fine needle aspiration diagnosis of cystic squamous lesions of the head and neck.
Chandan VS; Faquin WC; Wilbur DC; Khurana KK
Cancer; 2006 Apr; 108(2):124-8. PubMed ID: 16435376
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1.
Zhou SH; Fan J; Chen XM; Cheng KJ; Wang SQ
Head Neck; 2009 Dec; 31(12):1624-33. PubMed ID: 19441091
[TBL] [Abstract][Full Text] [Related]
31. Apigenin's anticancer properties and molecular mechanisms of action: Recent advances and future prospectives.
Salmani JMM; Zhang XP; Jacob JA; Chen BA
Chin J Nat Med; 2017 May; 15(5):321-329. PubMed ID: 28558867
[TBL] [Abstract][Full Text] [Related]
32. Head and neck cancer chemoprevention gets a shot in the arm.
Khuri FR; Shin DM
J Clin Oncol; 2008 Jan; 26(3):345-7. PubMed ID: 18202405
[No Abstract] [Full Text] [Related]
33. Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1.
Li ZD; Hu XW; Wang YT; Fang J
FEBS Lett; 2009 Jun; 583(12):1999-2003. PubMed ID: 19447105
[TBL] [Abstract][Full Text] [Related]
34. Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Taubert H; Schubert J; Bilkenroth U
Oncol Rep; 2008 Dec; 20(6):1381-5. PubMed ID: 19020718
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
36. [A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Inuyama Y; Miyake H; Horiuchi M; Hayasaki K; Komiyama S; Ota K
Gan To Kagaku Ryoho; 1992 Jun; 19(6):871-7. PubMed ID: 1605665
[TBL] [Abstract][Full Text] [Related]
37. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
[TBL] [Abstract][Full Text] [Related]
38. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.
Kondo Y; Yoshikawa K; Omura Y; Shinohara A; Kazaoka Y; Sano J; Mizuno Y; Yokoi T; Yamada S
Oncol Rep; 2011 May; 25(5):1227-33. PubMed ID: 21399882
[TBL] [Abstract][Full Text] [Related]
40. Altered gene and protein expression of glucose transporter1 underlies dexamethasone inhibition of insulin-stimulated glucose uptake in chicken muscles.
Zhao JP; Bao J; Wang XJ; Jiao HC; Song ZG; Lin H
J Anim Sci; 2012 Dec; 90(12):4337-45. PubMed ID: 22859751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
